• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Neuroendocrine tumors: is there a standard treatment?

作者信息

Kulke Matthew H

机构信息

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.

出版信息

Gastrointest Cancer Res. 2008 May;2(3):152-3.

PMID:19259293
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2633073/
Abstract
摘要

相似文献

1
Neuroendocrine tumors: is there a standard treatment?神经内分泌肿瘤：有标准治疗方法吗？
Gastrointest Cancer Res. 2008 May;2(3):152-3.
2
[2017 ENETS consensus guidelines: update for the standard of care of pancreatic neuroendocrine tumors].[2017年欧洲神经内分泌肿瘤学会（ENETS）共识指南：胰腺神经内分泌肿瘤护理标准的更新]
Zhonghua Wai Ke Za Zhi. 2018 Nov 1;56(11):809-812. doi: 10.3760/cma.j.issn.0529-5815.2018.11.003.
3
New clinical trials for the treatment of neuroendocrine tumors.神经内分泌肿瘤治疗的新临床试验。
Q J Nucl Med. 2000 Mar;44(1):96-101.
4
Chromogranin As a Biochemical Marker of Neuroendocrine Tumors.嗜铬粒蛋白作为神经内分泌肿瘤的生化标志物
Bull Exp Biol Med. 2016 Mar;160(5):702-4. doi: 10.1007/s10517-016-3254-0. Epub 2016 Mar 29.
5
Systemic treatment of neuroendocrine tumors with hepatic metastases.伴有肝转移的神经内分泌肿瘤的全身治疗
Turk J Gastroenterol. 2012;23(5):427-37. doi: 10.4318/tjg.2012.0552.
6
Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids.肺神经内分泌（类癌）肿瘤：欧洲神经内分泌肿瘤学会专家共识和典型与非典型肺类癌最佳实践建议。
Ann Oncol. 2015 Aug;26(8):1604-20. doi: 10.1093/annonc/mdv041. Epub 2015 Feb 2.
7
The Colorful Palette of Neuroendocrine Neoplasms in the Genitourinary Tract.泌尿生殖道神经内分泌肿瘤的多彩图谱
Anticancer Res. 2018 Jun;38(6):3243-3254. doi: 10.21873/anticanres.12589.
8
DTIC therapy in patients with malignant intra-abdominal neuroendocrine tumors.达卡巴嗪治疗腹腔内恶性神经内分泌肿瘤患者。
Surgery. 1987 Dec;102(6):1009-17.
9
Sinonasal malignancies with neuroendocrine differentiation: case series and review of literature.具有神经内分泌分化的鼻窦恶性肿瘤：病例系列及文献综述
Indian J Pathol Microbiol. 2010 Jan-Mar;53(1):28-34. doi: 10.4103/0377-4929.59179.
10
Plasma chromogranin A in prostatic carcinoma and neuroendocrine tumors.前列腺癌和神经内分泌肿瘤中的血浆嗜铬粒蛋白A
J Urol. 1997 Feb;157(2):565-8.

引用本文的文献

1
Kaposi's Sarcoma-Associated Herpesvirus Infection Induces the Expression of Neuroendocrine Genes in Endothelial Cells.卡波西肉瘤相关疱疹病毒感染诱导内皮细胞中神经内分泌基因的表达。
J Virol. 2020 Mar 31;94(8). doi: 10.1128/JVI.01692-19.
2
The impact of primary tumor site on outcomes of treatment with etoposide and cisplatin in grade 3 gastroenteropancreatic neuroendocrine carcinoma.原发性肿瘤部位对依托泊苷和顺铂治疗3级胃肠胰神经内分泌癌疗效的影响
J Cancer. 2019 Jun 2;10(14):3140-3144. doi: 10.7150/jca.30355. eCollection 2019.
3
Chromogranin A: From Laboratory to Clinical Aspects of Patients with Neuroendocrine Tumors.嗜铬粒蛋白A：从神经内分泌肿瘤患者的实验室研究到临床应用
Int J Endocrinol. 2018 Jul 2;2018:8126087. doi: 10.1155/2018/8126087. eCollection 2018.
4
The LARO-MEN1 study: a longitudinal clinical experience with octreotide Long-Acting Release in patients with Multiple Endocrine Neoplasia type 1 Syndrome.LARO-MEN1研究：1型多发性内分泌肿瘤综合征患者使用长效奥曲肽的纵向临床经验。
Clin Cases Miner Bone Metab. 2017 May-Aug;14(2):123-130. doi: 10.11138/ccmbm/2017.14.1.123. Epub 2017 Oct 25.
5
The impact of pathologic differentiation (well/poorly) and the degree of Ki-67 index in patients with metastatic WHO grade 3 GEP-NECs.病理分化程度（良好/不良）及Ki-67指数水平对WHO 3级转移性胃肠胰神经内分泌癌患者的影响
Oncotarget. 2017 May 25;8(43):73974-73980. doi: 10.18632/oncotarget.18168. eCollection 2017 Sep 26.
6
Loss of DPC4/SMAD4 expression in primary gastrointestinal neuroendocrine tumors is associated with cancer-related death after resection.原发性胃肠道神经内分泌肿瘤中DPC4/SMAD4表达缺失与切除术后癌症相关死亡有关。
Surgery. 2017 Mar;161(3):753-759. doi: 10.1016/j.surg.2016.09.002. Epub 2016 Nov 3.
7
The PARP inhibitor ABT-888 potentiates dacarbazine-induced cell death in carcinoids.聚（ADP-核糖）聚合酶（PARP）抑制剂ABT-888增强达卡巴嗪诱导的类癌细胞死亡。
Cancer Gene Ther. 2016 Oct;23(10):348-354. doi: 10.1038/cgt.2016.39. Epub 2016 Sep 16.
8
Targeted radionuclide therapy.靶向放射性核素治疗。
Cancers (Basel). 2011 Oct 11;3(4):3838-55. doi: 10.3390/cancers3043838.
9
Multimodal management of neuroendocrine liver metastases.神经内分泌肝脏转移的多模态管理。
HPB (Oxford). 2010 Aug;12(6):361-79. doi: 10.1111/j.1477-2574.2010.00175.x.
10
The role of antiangiogenesis therapy: bevacizumab and beyond.抗血管生成疗法的作用：贝伐单抗及其他。
Clin Transl Oncol. 2009 Jun;11(6):349-55. doi: 10.1007/s12094-009-0368-0.

本文引用的文献

1
Biology and treatment of metastatic gastrointestinal neuroendocrine tumors.转移性胃肠道神经内分泌肿瘤的生物学特性与治疗
Gastrointest Cancer Res. 2008 May;2(3):113-25.
2
Targeting vascular endothelial growth factor in advanced carcinoid tumor: a random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alpha-2b.在晚期类癌肿瘤中靶向血管内皮生长因子：一项关于长效奥曲肽联合贝伐单抗和聚乙二醇化干扰素α-2b的随机分配II期研究。
J Clin Oncol. 2008 Mar 10;26(8):1316-23. doi: 10.1200/JCO.2007.13.6374.
3
Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors.替莫唑胺单药治疗对晚期恶性神经内分泌肿瘤有效。
Clin Cancer Res. 2007 May 15;13(10):2986-91. doi: 10.1158/1078-0432.CCR-06-2053.
4
A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas.替西罗莫司治疗晚期神经内分泌癌的II期临床及药效学研究
Br J Cancer. 2006 Nov 6;95(9):1148-54. doi: 10.1038/sj.bjc.6603419. Epub 2006 Oct 10.
5
Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors.替莫唑胺与沙利度胺治疗转移性神经内分泌肿瘤患者的II期研究。
J Clin Oncol. 2006 Jan 20;24(3):401-6. doi: 10.1200/JCO.2005.03.6046.
6
Radiolabeled somatostatin analog [177Lu-DOTA0,Tyr3]octreotate in patients with endocrine gastroenteropancreatic tumors.放射性标记的生长抑素类似物[177Lu-DOTA0,Tyr3]奥曲肽用于内分泌性胃肠胰腺肿瘤患者
J Clin Oncol. 2005 Apr 20;23(12):2754-62. doi: 10.1200/JCO.2005.08.066.
7
Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas.氟尿嘧啶、多柔比星和链脲佐菌素治疗局部晚期和转移性胰腺内分泌癌患者
J Clin Oncol. 2004 Dec 1;22(23):4762-71. doi: 10.1200/JCO.2004.04.024.
8
90Y-DOTA-D-Phe1-Try3-octreotide in therapy of neuroendocrine malignancies.90Y-多胺基大环配体-右旋苯丙氨酸1-色氨酸3-奥曲肽治疗神经内分泌恶性肿瘤
Biopolymers. 2002;66(6):393-8. doi: 10.1002/bip.10349.
9
Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA(0),Tyr3]octreotate.用新型放射性标记的生长抑素类似物[177Lu-DOTA(0),Tyr3]奥曲肽治疗胃肠胰（GEP）肿瘤患者。
Eur J Nucl Med Mol Imaging. 2003 Mar;30(3):417-22. doi: 10.1007/s00259-002-1050-8. Epub 2003 Jan 9.
10
Long-term efficacy of high-activity 111in-pentetreotide therapy in patients with disseminated neuroendocrine tumors.高活性111铟-奥曲肽治疗播散性神经内分泌肿瘤患者的长期疗效
J Nucl Med. 2003 Jan;44(1):1-6.